News Image

Friday's session: gap up and gap down stocks

By Mill Chart

Last update: Jul 1, 2022

Let's have a look at the gap up and gap down stocks in today's session.

Top Gap up stocks

TickerChangeComment
QNRX64.36%Quoin Pharmaceuticals Ltd's (NASDAQ:QNRX) shares rose 64.36% to $0.74 with a gap of 34.9% during Friday's session. The stock is trading 29.36% lower than a month ago.
NRG.W57.62%ENERGY VAULT HLDS CL A-CW27 (NYSE:NRG.W) rose 57.62% to $2.38 with a gap of 25.0% during Friday's session. In the last month the share price dropped with 66.44%.
ALNA50.79%Allena Pharmaceuticals Inc's (NASDAQ:ALNA) stock price increased by 50.79% to $0.29 with a gap of 9.24%. In the last month the share price increased with 54.41%.
AKBA23.76%Akebia Therapeutics Inc (NASDAQ:AKBA) rose 23.76% to $0.44 with a gap of 18.73% during Friday's session. Shareholders saw the stock price going 47.12% lower in the past 3 months.
MOHO23.19%ECMOHO Limited's (NASDAQ:MOHO) stock price is advancing with 23.19% to a price of $0.2 with a gap of 5.56%. The stock is trading 41.02% lower than 3 months ago.
FSRD17.46%Fast Radius Inc's (NASDAQ:FSRD) shares rose 17.46% to $0.74 with a gap of 7.12%. The stock is trading 54.38% lower than 3 months ago.
SXTC16.57%China SXT Pharmaceuticals Inc's (NASDAQ:SXTC) stock price is advancing with 16.57% to a price of $2.04 with a gap of 2.21%. Shareholders saw the stock price going 573.0% higher in the past 3 months.
BRQS15.57%Borqs Technologies Inc's (NASDAQ:BRQS) shares rose 15.57% to $1.93 with a gap of 7.91% during Friday's session. Shareholders saw the stock price going 40.22% lower in the past month.
CASI4.55%CASI Pharmaceuticals Inc's (NASDAQ:CASI) stock price is advancing with 4.55% to a price of $2.99 with a gap of 4.55%. In the last month the stock lost 29.61%.
LUCD3.98%Lucid Diagnostics Inc's (NASDAQ:LUCD) stock price increased by 3.98% to $2.35 with a gap of 3.98%. Shareholders saw the stock price going 34.3% lower in the past 3 months.

For the full gap up stocks list go to our gap up stocks screener.

Today's top gap down stocks

TickerChangeComment
AGRX-42.88%Agile Therapeutics Inc's (NASDAQ:AGRX) stock price is declining with 42.88% to a price of $0.67 with a gap of 59.8%. Shareholders saw the stock price going 85.88% lower in the past 3 months.
ENSC-26.27%Ensysce Biosciences Inc's (NASDAQ:ENSC) shares fell 26.27% to $0.64 during Friday's session with a gap of 30.43%. A press release (Ensysce Biosciences Secures $8 Million Convertible Note Financing) was released earlier today.
KSS-20.69%Kohls Corporation's (NYSE:KSS) shares fell 20.69% to $28.3 during Friday's session with a gap of 21.33%. In the last 3 months the share price dropped with 40.85%.
DRMA-18.46%Dermata Therapeutics Inc's (NASDAQ:DRMA) shares fell 18.46% to $0.53 during Friday's session with a gap of 51.44%. In the last 3 months the stock lost 49.21%.
BORR-17.57%Borr Drilling Limited's (NYSE:BORR) shares fell 17.57% to $3.8 with a gap of 22.93%. Yesterday the company had a press release: Borr Drilling Limited - Update on Refinance.
TKLF-17.16%Yoshitsu Company Ltd's (NASDAQ:TKLF) shares fell 17.16% to $1.4 with a gap of 31.71%. Shareholders saw the stock price going 23.36% higher in the past month.
CLDX-16.1%Celldex Therapeutics Inc's (NASDAQ:CLDX) shares fell 16.1% to $22.62 during Friday's session with a gap of 20.73%. Shareholders saw the stock price going 20.92% lower in the past 3 months.
MTC-15.88%MMTec Inc's (NASDAQ:MTC) shares fell 15.88% to $0.25 with a gap of 43.03%. The stock is trading 53.21% lower than 3 months ago.
AFIB-14.37%Acutus Medical Inc's (NASDAQ:AFIB) shares fell 14.37% to $0.96 during Friday's session with a gap of 20.0%. Shareholders saw the stock price going 74.84% higher in the past month.
OAS-14.35%Oasis Petroleum Inc's (NASDAQ:OAS) stock price decreased by 14.35% to $104.19 with a gap of 20.01%. The stock is trading 26.41% lower than a month ago.

For the full top loser list go to our gap down stocks screener.

Back

CELLDEX THERAPEUTICS INC

NASDAQ:CLDX (4/26/2024, 7:00:00 PM)

After market: 36.3 0 (0%)

36.3

+0.04 (+0.11%)

CLDX News

News Image3 days ago - Market News VideoCelldex Therapeutics is Now Oversold (CLDX)
News Image11 days ago - Celldex Therapeutics, Inc.Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
News Image2 months ago - Celldex Therapeutics, Inc.Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
News Image2 months ago - Celldex Therapeutics, Inc.Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference

HAMPTON, N.J., March 08, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside...

News Image2 months ago - Market News VideoInvestors Land CLDX Even Cheaper Than Its Secondary Stock Offering
News Image2 months ago - Market News VideoNotable Wednesday Option Activity: CLDX, GOOG, PSFE
News Image2 months ago - Celldex Therapeutics, Inc.Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference
News Image2 months ago - Celldex Therapeutics, Inc.Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference

HAMPTON, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that Anthony S. Marucci, President and Chief...

News Image2 months ago - Celldex Therapeutics, Inc.Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
News Image2 months ago - Celldex Therapeutics, Inc.Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

HAMPTON, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the closing of...

News Image2 months ago - Seeking AlphaCelldex prices $400.4M stock offering (NASDAQ:CLDX)

Celldex Therapeutics prices stock offering to raise $400.4M for clinical development of product candidates and general corporate purposes.

News Image2 months ago - Celldex Therapeutics, Inc.Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock
CLDX Links
Follow us for more